REQUEST A DEMO
Total
USD $0.00
Search more companies

Slavia Pharm SRL (Romania)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Slavia Pharm SRL Profile Updated: August 22, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Slavia Pharm SRL is a company in Romania, with a head office in Bucharest. The company operates in the Pharmaceutical Preparation Manufacturing industry. Slavia Pharm SRL was incorporated on May 12, 1997. It currently has a total number of 151 (2022) employees. From the latest financial highlights, Slavia Pharm SRL reported a net sales revenue increase of 14.31% in 2022. There was a total growth of 12.32% in Slavia Pharm SRL’s total assets over the same period. The net profit margin of Slavia Pharm SRL decreased by 6.03% in 2022.

Headquarters
Bulevardul Theodor Pallady Nr. 44C
Bucharest; Bucharest;

Contact Details: Purchase the Slavia Pharm SRL report to view the information.

Basic Information
Total Employees:
Purchase the Slavia Pharm SRL report to view the information.
Outstanding Shares:
Purchase the Slavia Pharm SRL report to view the information.
Registered Capital:
Purchase the Slavia Pharm SRL report to view the information.
Incorporation Date:
May 12, 1997
Key Executives
Purchase this report to view the information.
Administrator
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Subsidiaries
Poli Generika SRL
100%
Company Performance
Financial values in the chart are available after Slavia Pharm SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
14.31%
Total operating revenue
12.92%
Operating profit (EBIT)
-1.3%
EBITDA
12.46%
Net Profit (Loss) for the Period
-18.31%
Total assets
12.32%
Total equity
8.6%
Operating Profit Margin (ROS)
-3.08%
Net Profit Margin
-6.03%
Return on Equity (ROE)
-5.64%
Debt to Equity Ratio
0.39%
Quick Ratio
0.25%
Cash Ratio
-0.05%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?